Kazuyoshi Kuwano Selected Research

ribophorin

2/2015	Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer.
11/2013	A novel platform to enable inhaled naked RNAi medicine for lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuyoshi Kuwano Research Topics

Disease

24	Fibrosis (Cirrhosis) 07/2022 - 05/2002
22	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 08/2009
18	Neoplasms (Cancer) 10/2021 - 03/2011
16	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2022 - 03/2002
13	Idiopathic Pulmonary Fibrosis 11/2021 - 03/2002
13	Pneumonia (Pneumonitis) 08/2021 - 11/2002
12	Lung Neoplasms (Lung Cancer) 04/2020 - 11/2002
10	Asthma (Bronchial Asthma) 06/2022 - 06/2004
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 03/2011
10	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 06/2002
10	Lung Diseases (Lung Disease) 10/2018 - 03/2002
9	Lung Injury 12/2017 - 05/2002
7	Inflammation (Inflammations) 01/2022 - 08/2007
7	Infections 01/2021 - 08/2011
7	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2013
6	Respiratory Insufficiency (Respiratory Failure) 10/2020 - 12/2002
6	Adenocarcinoma of Lung 01/2020 - 01/2014
5	Bronchiectasis 11/2021 - 01/2018
5	Pleural Effusion (Pleural Effusions) 04/2021 - 01/2013
4	Tuberculosis (Tuberculoses) 01/2021 - 11/2016
4	Pleurisy (Pleuritis) 01/2020 - 08/2011
4	Rheumatoid Arthritis 01/2019 - 08/2011
3	Necrosis 01/2022 - 01/2020
3	Cysts 08/2021 - 01/2012
3	Cough 08/2021 - 09/2014
3	COVID-19 01/2021 - 01/2020
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 05/2013
3	Disease Progression 01/2018 - 03/2002
3	Acute Lung Injury 01/2017 - 10/2008
3	Pneumothorax 01/2014 - 08/2011
2	Sinusitis 06/2022 - 03/2018
2	Respiratory Sounds (Crackle) 01/2022 - 08/2021
2	Granuloma 01/2022 - 08/2003
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2021 - 12/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2013
2	Idiopathic Interstitial Pneumonias 04/2020 - 01/2016
2	Carcinoma (Carcinomatosis) 08/2019 - 06/2019
2	Melanoma (Melanoma, Malignant) 06/2019 - 01/2015
2	Organizing Pneumonia 03/2019 - 01/2012
2	Abscess 01/2019 - 11/2012
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019 - 01/2006
2	Systemic Scleroderma (Systemic Sclerosis) 02/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

16	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 04/2004
15	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2021 - 03/2002
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
12	SmokeIBA 01/2022 - 03/2012
10	Pharmaceutical PreparationsIBA 08/2021 - 02/2013
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
7	Biological ProductsIBA 01/2022 - 02/2006
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2013
5	Monoclonal AntibodiesIBA 01/2022 - 01/2018
5	CytokinesIBA 01/2022 - 12/2007
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 03/2011
5	SteroidsIBA 10/2020 - 06/2004
5	Phosphotransferases (Kinase)IBA 01/2020 - 11/2002
4	NivolumabIBA 04/2021 - 01/2018
4	pirfenidoneIBA 01/2021 - 01/2016
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2011
4	pembrolizumabIBA 10/2020 - 08/2019
4	MicroRNAs (MicroRNA)IBA 01/2020 - 02/2013
4	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 09/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2018 - 11/2012
3	AcidsIBA 01/2022 - 08/2003
3	InterleukinsIBA 01/2022 - 01/2019
3	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2019
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 01/2015
3	LigandsIBA 01/2019 - 03/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2012
3	Methotrexate (Mexate)FDA LinkGeneric 01/2016 - 08/2011
3	Fas Ligand Protein (Fas Ligand)IBA 06/2002 - 03/2002
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2022 - 11/2021
2	Peroxidase (Myeloperoxidase)IBA 07/2022 - 11/2021
2	dupilumabIBA 06/2022 - 01/2022
2	benralizumabIBA 01/2022 - 08/2020
2	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 02/2015
2	PlatinumIBA 11/2020 - 04/2015
2	Immune Checkpoint InhibitorsIBA 10/2020 - 08/2019
2	Methylprednisolone FDA LinkGeneric 10/2020 - 01/2015
2	mepolizumabIBA 08/2020 - 10/2019
2	Adenosine DeaminaseIBA 01/2020 - 01/2017
2	CaspasesIBA 01/2020 - 12/2002
2	IronIBA 01/2020 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2006
2	ProstaglandinsIBA 06/2019 - 01/2017
2	11 alpha- hydroxy- 9,15- dioxo- 2,3,4,5,20- pentanor- 19- carboxyprostanoic acidIBA 06/2019 - 01/2017
2	AntigensIBA 06/2019 - 05/2013
2	Itraconazole (Sporanox)FDA LinkGeneric 01/2019 - 12/2002
2	ChemokinesIBA 01/2019 - 05/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 08/2011
2	LipopolysaccharidesIBA 01/2019 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 01/2008
2	AntibodiesIBA 01/2018 - 05/2013
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 02/2017 - 03/2002
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2017 - 09/2008
2	naphthaleneIBA 01/2017 - 03/2011

Therapy/Procedure

32	Therapeutics 05/2021 - 03/2002
7	Drug Therapy (Chemotherapy) 04/2020 - 12/2008
5	Traction 11/2021 - 01/2018
2	Local Anesthesia 01/2021 - 01/2013
2	Aftercare (After-Treatment) 01/2019 - 05/2013